Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
|---|---|---|---|---|---|
| Net Income | 4.30% | -111.34% | 1,191.16% | -1.61% | 11.68% |
| Total Depreciation and Amortization | 329.23% | -86.17% | 1,324.24% | -88.93% | -67.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 430.00% | 100.15% | -- | -100.00% | -- |
| Change in Net Operating Assets | -2,191.49% | 101.67% | -962.72% | -47.93% | -31.03% |
| Cash from Operations | -98.93% | 76.11% | -721.47% | -996.04% | -147.07% |
| Capital Expenditure | -106.10% | 142.57% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | -106.10% | -95.36% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 635.98% | -326.74% |
| Total Debt Repaid | 1,049.10% | 88.22% | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,089.79% | 88.19% | -408.34% | 635.98% | -326.74% |
| Foreign Exchange rate Adjustments | -250.00% | -166.67% | 98.25% | -251.33% | 362.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.54% | -188.35% | 69,535.29% | 101.05% | -197.64% |